Specialties

Which subgroup of patients with type 2 diabetes and heart failure is more beneficial from treatment with canagliflozin? Patients with type 2 diabetes are at risk for many cardiovascular diseases, including heart failure. In a cohort study published by Nichols et al., patients with type 2 diabetes are more likely …

Finding a precise mechanism behind birth defects in fetuses of periconceptually diagnosed patients with diabetes is a step closer in identifying preventative measures With more than three million women of birthing age in the US and more than sixty million worldwide with diabetes, it is essential to know how diabetes …

A Look into how insulin detemir causes an increased risk of malformations and even death for neonates with mothers who are insulin dependent. Chances of adverse maternal and fetal outcomes are increased when mothers have diabetes and even higher if the patient has uncontrolled diabetes. The increased adverse effects can …

According to research presented by Dr. Karim Gariani from the University of Zurich, three and six weeks of therapy give similar incidences of remission in diabetic foot osteomyelitis. Diabetic foot infections are either bone or soft tissue infections below the malleoli. It is the most common issue that can come …

Serum DPP4 levels may be associated with cognitive dysfunction in perinatal pregnant women with gestational diabetes mellitus  Gestational diabetes mellitus (GDM) occurs in about 7% of all pregnancies, ranging from 1% to 14%, depending on the specific population studied, and the diagnostic test used to assess the presence of gestational …

New retrospective study results compare the two most largely prescribed antidiabetic medication classes in addition to metformin, to determine the impact on the incidence of CV events in patients with T2DM. Dipeptidyl-peptidase-4 inhibitors (DPP-4i) and sulphonylureas (sulfonylureas in the US) (SU) are two of the most prescribed medication to date …

A comprehensive study reveals the importance of ophthalmologic and otologic care in patients with T2DM due to the association of increased risks for cardiovascular events in those with a decline in vision and hearing abilities. It is known that patients with type 2 diabetes mellitus (T2DM) have an increased risk …

In the SWEET project experience, a large cohort of patients was started on either an insulin pump, glucose sensor, or both to compare the HbA1c levels and weight gain while on their new therapy. Many health complications can arise from diabetes, especially for adolescents and children with type 1 diabetes, …

Effective preventive strategies are needed to reduce cardiovascular disease, the leading cause of mortality and morbidity globally.

Glucagon-like peptide-1 (GLP-1) receptor agonist can reduce mortality and improve cardiovascular outcomes among patients with type 2 diabetes and end-stage kidney disease, compared to dipeptidyl peptidase -4 inhibitor use.